Global Recombinant Proteins Market Report 2024

Recombinant Proteins Global Market Report 2024 – By Product (Antibodies, Cytokines, Immune Checkpoint Protein, Virus Antigens, Enzymes, Recombinant Regulatory Proteins, Hormones, Other Products), By Application (Drug And Discovery Development, Therapeutics, Research, Other Applications), By End User (Pharmaceutical And Biotechnology Companies, Academic And Research Institute, Diagnostic Laboratories, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033

Starting Price : $5000.00 | Pages : | Published : January 2024 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options
Request Sample
Request For Discount
FAQs

Need assistance or more information before the purchase?

Enquire Before Buying
Recombinant Proteins Global Market Report 2023

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

Recombinant Proteins Market Definition And Segments

Recombinant proteins refer to modified or edited proteins encoded by recombinant DNA, made up of a plasmid in which the gene of an interest target protein is cloned downstream of a promoter region. They are used to make pharmaceuticals, protein-based polymers for drug delivery, antibodies and enzymes for disease treatment, protein scaffolds for tissue engineering, and a variety of other things.

The main types of recombinant protein products are antibodies, cytokines, immune checkpoint proteins, virus antigens, enzymes, recombinant regulatory proteins, hormones, and others. Antibodies refer to a protein immune system component that travels through the blood, detects foreign objects like bacteria and viruses, and destroys them. They are used in various applications such as drug and discovery development, therapeutics, research, and others. It is used mostly by pharmaceutical and biotechnology companies, academic and research institutes, diagnostic laboratories, and others.

The recombinant proteins market covered in this report is segmented –

1) By Product: Antibodies, Cytokines, Immune Checkpoint Protein, Virus Antigens, Enzymes, Recombinant Regulatory Proteins, Hormones, Other Products

2) By Application: Drug And Discovery Development, Therapeutics, Research, Other Applications

3) By End User: Pharmaceutical And Biotechnology Companies, Academic And Research Institute, Diagnostic Laboratories, Other End Users

The recombinant proteins market size has grown rapidly in recent years. It will grow from $2.12 billion in 2023 to $2.37 billion in 2024 at a compound annual growth rate (CAGR) of 11.6%. The growth in the historic period can be attributed to increasing demand for biopharmaceuticals, rising prevalence of chronic diseases, growing aging population, government initiatives and funding, expanding applications in research and diagnostics.

The recombinant proteins market size is expected to see rapid growth in the next few years. It will grow to $3.79 billion in 2028 at a compound annual growth rate (CAGR) of 12.5%. The growth in the forecast period can be attributed to increased adoption of personalized medicine, rapid expansion of the biotechnology sector, global efforts to address rare diseases, advancements in protein engineering techniques, emerging markets, and untapped opportunities. Major trends in the forecast period include expansion of personalized medicine, rapid growth in the biotechnology sector, demand for therapeutic proteins, emergence of novel therapeutic targets, global focus on vaccine development.

Rising Regulatory Approvals Fuel The Growth Of Recombinant Protein Market

A rising number of regulatory approvals is expected to propel the growth of the recombinant protein market going forward. Regulatory approvals refer to any government or health authority authorization for any research involving human subjects. A rising number of regulatory approvals for recombinant proteins is mandatory for all drugs, which includes the treatment of diabetes, and severe chronic diseases like cancer, cardiovascular diseases, endocrine diseases, and viral diseases. For instance, in January 2022, according to the Centre for Drug Evaluation and Research (CDER), a US-based non-profit organization, 38 (76%) of the 50 medications CDER authorized in 2021 received their first U.S. approval. In comparison to 21 of 53 first-in-class pharmaceuticals (39.5%) in 2020, first-in-class drugs made up 27 of the 50 drugs (54%) approved in 2021, the agency observed. The FDA previously reported that 20 drugs were approved (42%), 19 were approved (32%), and 15 were approved (33%). Therefore, the rising number of regulatory approvals is driving the growth of the recombinant protein market going forward.

Government-Led Healthcare Research And Development Initiatives A Boost For Recombinant Proteins Market

Government initiatives for research and development in healthcare are expected to propel the growth of the growth of the recombinant protein market going forward. Government initiatives refer to specific actions, programs, policies, or projects undertaken by government authorities at various levels (local, regional, national, or international) to address specific issues, achieve certain goals, or create positive changes in society. Several government authorities are initiating various healthcare initiatives to support various aspects including recombinant proteins. For instance, in 2022, according to the Department of Health and Social Care, a UK-based government authority, the UK government announced £260 million (US $270.65) million in funding to boost healthcare research and manufacturing. This was committed by BEIS and DHSC to support NHS-led health research into diagnostics and treatment through new privacy-preserving platforms and clinical research services, and £60 million (US $63.60 million) to help expand life sciences manufacturing in the UK. Therefore, government initiatives for research and development in healthcare drive the recombinant protein market.

Major companies operating in the recombinant proteins market report are Abcam PLC, Abnova Corporation, Bio-Rad Laboratoroies Inc., Merck Co. & KGaA, R&D Systems Inc., Proteintech Group Inc., RayBiotech Life Inc., GenScript Biotech Corporation, Elpiscience Biopharmaceuticals Co. Ltd., Elevian Inc., Gigagen Inc., Janssen- Cilag Pvt. Ltd., Sino Biological Inc., OriGene Technologies Inc., Feldan Therapeutics Inc., Randox Laboratories Ltd., Plant Biotechnology Inc., Infinite Enzymes Inc., Bio-Techne Corporation, Thermo Fisher Scientific Inc., PerkinElmer Inc., Crown Bioscience Inc., Airway Therapeutics Inc., Amgen Inc., Aviva Systems Biology Corp., Bracco Imaging S.p.A., Cardinal Health Inc., Eli Lilly and Company, Gamma Medica Inc., LambdaSpect Ltd. .

Innovative Product Developments Driving Recombinant Protein Market Growth

Product innovation is the key trend gaining popularity in the recombinant protein market. Major companies operating in the recombinant protein market are focused on developing innovative products to strengthen their position in the market. For instance, in March 2022, ProteoGenix, a France-based biochemistry company launched the XtenCHO Transient CHO Expression System, aimed at improving biologics development. This new system offers several advantages, including ten times higher yields, optimized plasmid stability, and smart protocols with less hands-on time. The XtenCHOsystem is designed to be a rapid and cost-effective solution, ideal for both bioanalytical applications and drug development.

Strategic Collaborations Driving Innovation And Market Competitiveness In Recombinant Protein Industry

Major companies operating in recombinant protein market are undergoing partnerships to gain a competitive edge in the market. Partnerships often foster innovation by combining the expertise of different entities. For instance, in October 2023, ARTES Biotechnology GmbH, a Germany-based biotechnology company collaborated with Basic Pharma, a Netherlands-based pharmaceutical company. The collaboration involves a strategic partnership and co-marketing agreement aimed at developing and producing non-GMP recombinant proteins, with a focus on establishing a streamlined supply chain process to expedite the time-to-market for new pharmaceutical products.

Thermo Fisher's Strategic Acquisition Of Peprotech Advancing Capabilities In Recombinant Protein Solutions

In December 2021, Thermo Fisher Scientific Inc., a US-based supplier of scientific instrumentation, reagents, and consumables, acquired PeproTech, Inc. for an undisclosed amount. Through this acquisition, Thermo Fisher Scientific Inc. increases its capabilities for serving high-growth cells and gene therapy. Thermo Fisher's cell culture media products will benefit from PeproTech's recombinant protein portfolio, allowing Thermo Fisher to provide clients with considerable benefits through an integrated offering. PeproTech Inc. is a recombinant protein producer situated in the United States that develops and manufactures recombinant cytokine products for life science research.

North America was the largest region in the recombinant protein market in 2023. The regions covered in the recombinant proteins market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the recombinant proteins market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The recombinant protein market consists of sales of recombinant monoclonal antibodies, interferons, and interleukins. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The recombinant proteins market research report is one of a series of new reports from The Business Research Company that provides recombinant proteins market statistics, including recombinant proteins industry global market size, regional shares, competitors with a recombinant proteins market share, detailed recombinant proteins market segments, market trends and opportunities, and any further data you may need to thrive in the recombinant proteins industry. The recombinant proteins market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Recombinant Proteins Market Report Scope
Report AttributeDetails
Market Size Value In 2024 $2.37 billion
Revenue Forecast In 2033 $3.79 billion
Growth Rate CAGR of 12.5% from 2024 to 2033
Base Year For Estimation 2023
Actual Estimates/Historical Data 2018-2023
Forecast Period 2024 - 2028 - 2033
Market Representation Revenue in USD Billion and CAGR from 2024 to 2033
Segments Covered 1) By Product: Antibodies, Cytokines, Immune Checkpoint Protein, Virus Antigens, Enzymes, Recombinant Regulatory Proteins, Hormones, Other Products
2) By Application: Drug And Discovery Development, Therapeutics, Research, Other Applications
3) By End User: Pharmaceutical And Biotechnology Companies, Academic And Research Institute, Diagnostic Laboratories, Other End Users
Regional Scope Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Country Scope Australia; China; India; Indonesia; Japan; South Korea; Bangladesh; Thailand; Vietnam; Malaysia; Singapore; Philippines; Hong Kong; New Zealand; USA; Canada; Mexico; Brazil; Chile; Argentina; Colombia; Peru; France; Germany; UK; Austria; Belgium; Denmark; Finland; Ireland; Italy; Netherlands; Norway; Portugal; Spain; Sweden; Switzerland; Russia; Czech Republic; Poland; Romania; Ukraine; Saudi Arabia; Israel; Iran; Turkey; UAE; Egypt; Nigeria; South Africa
Key Companies Profiled Abcam plc; Abnova Corporation; Bio-Rad Laboratoroies Inc.; Merck Co. & KGaA; R&D Systems Inc.; Proteintech Group Inc.; RayBiotech Life Inc.; GenScript Biotech Corporation; Elpiscience Biopharmaceuticals Co. Ltd.; Elevian Inc.; Gigagen Inc.; Janssen- Cilag Pvt. Ltd.; Sino Biological Inc.; OriGene Technologies Inc.; Feldan Therapeutics Inc.; Randox Laboratories Ltd.; Plant Biotechnology Inc.; Infinite Enzymes Inc.; Bio-Techne Corporation; Thermo Fisher Scientific Inc.; PerkinElmer Inc.; Crown Bioscience Inc.; Airway Therapeutics Inc.; Amgen Inc.; Aviva Systems Biology Corp.; Bracco Imaging S.p.A.; Cardinal Health Inc.; Eli Lilly and Company; Gamma Medica Inc.; LambdaSpect Ltd.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Recombinant Proteins Market Characteristics

    3. Recombinant Proteins Market Trends And Strategies

    4. Recombinant Proteins Market - Macro Economic Scenario

    4.1. Impact Of High Inflation On the Market

    4.2. Ukraine-Russia War Impact On the Market

    4.3. COVID-19 Impact On the Market

    5. Global Recombinant Proteins Market Size and Growth

    5.1. Global Recombinant Proteins Market Drivers and Restraints

    5.1.1. Drivers Of The Market

    5.1.2. Restraints Of The Market

    5.2. Global Recombinant Proteins Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)

    5.3. Global Recombinant Proteins Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

    6. Recombinant Proteins Market Segmentation

    6.1. Global Recombinant Proteins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Antibodies

    Cytokines

    Immune Checkpoint Protein

    Virus Antigens

    Enzymes

    Recombinant Regulatory Proteins

    Hormones

    Other Products

    6.2. Global Recombinant Proteins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Drug And Discovery Development

    Therapeutics

    Research

    Other Applications

    6.3. Global Recombinant Proteins Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Pharmaceutical And Biotechnology Companies

    Academic And Research Institute

    Diagnostic Laboratories

    Other End Users

    7. Recombinant Proteins Market Regional And Country Analysis

    7.1. Global Recombinant Proteins Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    7.2. Global Recombinant Proteins Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8. Asia-Pacific Recombinant Proteins Market  

    8.1. Asia-Pacific Recombinant Proteins Market Overview  

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Recombinant Proteins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.3. Asia-Pacific Recombinant Proteins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.4. Asia-Pacific Recombinant Proteins Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    9. China Recombinant Proteins Market  

    9.1. China Recombinant Proteins Market Overview  

    9.2. China Recombinant Proteins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.3. China Recombinant Proteins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.4. China Recombinant Proteins Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    10. India Recombinant Proteins Market  

    10.1. India Recombinant Proteins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.2. India Recombinant Proteins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.3. India Recombinant Proteins Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11. Japan Recombinant Proteins Market  

    11.1. Japan Recombinant Proteins Market Overview  

    11.2. Japan Recombinant Proteins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.3. Japan Recombinant Proteins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.4. Japan Recombinant Proteins Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12. Australia Recombinant Proteins Market  

    12.1. Australia Recombinant Proteins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.2. Australia Recombinant Proteins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.3. Australia Recombinant Proteins Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13. Indonesia Recombinant Proteins Market  

    13.1. Indonesia Recombinant Proteins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.2. Indonesia Recombinant Proteins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.3. Indonesia Recombinant Proteins Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14. South Korea Recombinant Proteins Market  

    14.1. South Korea Recombinant Proteins Market Overview  

    14.2. South Korea Recombinant Proteins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.3. South Korea Recombinant Proteins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.4. South Korea Recombinant Proteins Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15. Western Europe Recombinant Proteins Market  

    15.1. Western Europe Recombinant Proteins Market Overview

    15.2. Western Europe Recombinant Proteins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.3. Western Europe Recombinant Proteins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.4. Western Europe Recombinant Proteins Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16. UK Recombinant Proteins Market  

    16.1. UK Recombinant Proteins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.2. UK Recombinant Proteins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.3. UK Recombinant Proteins Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17. Germany Recombinant Proteins Market  

    17.1. Germany Recombinant Proteins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.2. Germany Recombinant Proteins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.3. Germany Recombinant Proteins Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18. France Recombinant Proteins Market  

    18.5. France Recombinant Proteins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.6. France Recombinant Proteins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.7. France Recombinant Proteins Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19. Italy Recombinant Proteins Market  

    19.9. Italy Recombinant Proteins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.10. Italy Recombinant Proteins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.11. Italy Recombinant Proteins Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20. Spain Recombinant Proteins Market  

    20.13. Spain Recombinant Proteins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.14. Spain Recombinant Proteins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.15. Spain Recombinant Proteins Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21. Eastern Europe Recombinant Proteins Market  

    21.1. Eastern Europe Recombinant Proteins Market Overview

    21.2. Eastern Europe Recombinant Proteins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.3. Eastern Europe Recombinant Proteins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.4. Eastern Europe Recombinant Proteins Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22. Russia Recombinant Proteins Market  

    22.1. Russia Recombinant Proteins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.2. Russia Recombinant Proteins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.3. Russia Recombinant Proteins Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23. North America Recombinant Proteins Market  

    23.1. North America Recombinant Proteins Market Overview

    23.2. North America Recombinant Proteins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.3. North America Recombinant Proteins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.4. North America Recombinant Proteins Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24. USA Recombinant Proteins Market  

    24.1. USA Recombinant Proteins Market Overview

    24.2. USA Recombinant Proteins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.3. USA Recombinant Proteins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.4. USA Recombinant Proteins Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25. Canada Recombinant Proteins Market  

    25.1. Canada Recombinant Proteins Market Overview

    25.2. Canada Recombinant Proteins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.3. Canada Recombinant Proteins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.4. Canada Recombinant Proteins Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26. South America Recombinant Proteins Market  

    26.1. South America Recombinant Proteins Market Overview

    26.2. South America Recombinant Proteins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.3. South America Recombinant Proteins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.4. South America Recombinant Proteins Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27. Brazil Recombinant Proteins Market  

    27.1. Brazil Recombinant Proteins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.2. Brazil Recombinant Proteins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.3. Brazil Recombinant Proteins Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28. Middle East Recombinant Proteins Market  

    28.1. Middle East Recombinant Proteins Market Overview

    28.2. Middle East Recombinant Proteins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.3. Middle East Recombinant Proteins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.4. Middle East Recombinant Proteins Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29. Africa Recombinant Proteins Market  

    29.1. Africa Recombinant Proteins Market Overview

    29.2. Africa Recombinant Proteins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.3. Africa Recombinant Proteins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.4. Africa Recombinant Proteins Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    30. Recombinant Proteins Market Competitive Landscape And Company Profiles

    30.1. Recombinant Proteins Market Competitive Landscape

    30.2. Recombinant Proteins Market Company Profiles

    30.2.1. Abcam plc

    30.2.1.1. Overview

    30.2.1.2. Products and Services

    30.2.1.3. Strategy

    30.2.1.4. Financial Performance

    30.2.2. Abnova Corporation

    30.2.2.1. Overview

    30.2.2.2. Products and Services

    30.2.2.3. Strategy

    30.2.2.4. Financial Performance

    30.2.3. Bio-Rad Laboratoroies Inc.

    30.2.3.1. Overview

    30.2.3.2. Products and Services

    30.2.3.3. Strategy

    30.2.3.4. Financial Performance

    30.2.4. Merck Co. &  KGaA

    30.2.4.1. Overview

    30.2.4.2. Products and Services

    30.2.4.3. Strategy

    30.2.4.4. Financial Performance

    30.2.5. R&D Systems Inc.

    30.2.5.1. Overview

    30.2.5.2. Products and Services

    30.2.5.3. Strategy

    30.2.5.4. Financial Performance

    31. Global Recombinant Proteins Market Competitive Benchmarking

    32. Global Recombinant Proteins Market Competitive Dashboard

    33. Key Mergers And Acquisitions In The Recombinant Proteins Market

    34. Recombinant Proteins Market Future Outlook and Potential Analysis

    34.1 Recombinant Proteins Market In 2028 - Countries Offering Most New Opportunities

    34.2 Recombinant Proteins Market In 2028 - Segments Offering Most New Opportunities

    34.3 Recombinant Proteins Market In 2028 - Growth Strategies

    34.3.1 Market Trend Based Strategies

    34.3.2 Competitor Strategies

    35. Appendix

    35.1. Abbreviations

    35.2. Currencies

    35.3. Historic And Forecast Inflation Rates

    35.4. Research Inquiries

    35.5. The Business Research Company

    35.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 3: Global Recombinant Proteins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 4: Global Recombinant Proteins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 5: Global Recombinant Proteins Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 6: Global Recombinant Proteins Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 7: Global Recombinant Proteins Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 8: Asia-Pacific, Recombinant Proteins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 9: Asia-Pacific, Recombinant Proteins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 10: Asia-Pacific, Recombinant Proteins Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 11: China, Recombinant Proteins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 12: China, Recombinant Proteins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 13: China, Recombinant Proteins Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 14: India, Recombinant Proteins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 15: India, Recombinant Proteins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 16: India, Recombinant Proteins Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 17: Japan, Recombinant Proteins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 18: Japan, Recombinant Proteins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 19: Japan, Recombinant Proteins Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 20: Australia, Recombinant Proteins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 21: Australia, Recombinant Proteins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 22: Australia, Recombinant Proteins Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 23: Indonesia, Recombinant Proteins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 24: Indonesia, Recombinant Proteins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 25: Indonesia, Recombinant Proteins Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 26: South Korea, Recombinant Proteins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 27: South Korea, Recombinant Proteins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 28: South Korea, Recombinant Proteins Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 29: Western Europe, Recombinant Proteins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 30: Western Europe, Recombinant Proteins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 31: Western Europe, Recombinant Proteins Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 32: UK, Recombinant Proteins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 33: UK, Recombinant Proteins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 34: UK, Recombinant Proteins Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 35: Germany, Recombinant Proteins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 36: Germany, Recombinant Proteins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 37: Germany, Recombinant Proteins Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 38: France, Recombinant Proteins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 39: France, Recombinant Proteins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 40: France, Recombinant Proteins Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 41: Italy, Recombinant Proteins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 42: Italy, Recombinant Proteins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 43: Italy, Recombinant Proteins Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 44: Spain, Recombinant Proteins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 45: Spain, Recombinant Proteins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 46: Spain, Recombinant Proteins Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 47: Eastern Europe, Recombinant Proteins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 48: Eastern Europe, Recombinant Proteins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 49: Eastern Europe, Recombinant Proteins Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 50: Russia, Recombinant Proteins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 51: Russia, Recombinant Proteins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 52: Russia, Recombinant Proteins Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 53: North America, Recombinant Proteins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 54: North America, Recombinant Proteins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 55: North America, Recombinant Proteins Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 56: USA, Recombinant Proteins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 57: USA, Recombinant Proteins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 58: USA, Recombinant Proteins Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 59: Canada, Recombinant Proteins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 60: Canada, Recombinant Proteins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 61: Canada, Recombinant Proteins Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 62: South America, Recombinant Proteins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 63: South America, Recombinant Proteins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 64: South America, Recombinant Proteins Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 65: Brazil, Recombinant Proteins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 66: Brazil, Recombinant Proteins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 67: Brazil, Recombinant Proteins Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 68: Middle East, Recombinant Proteins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 69: Middle East, Recombinant Proteins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 70: Middle East, Recombinant Proteins Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 71: Africa, Recombinant Proteins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 72: Africa, Recombinant Proteins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 73: Africa, Recombinant Proteins Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 74: Abcam plc Financial Performance
  • Table 75: Abnova Corporation Financial Performance
  • Table 76: Bio-Rad Laboratoroies Inc. Financial Performance
  • Table 77: Merck Co. &  KGaA Financial Performance
  • Table 78: R&D Systems Inc. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Figure 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 3: Global Recombinant Proteins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 4: Global Recombinant Proteins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 5: Global Recombinant Proteins Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 6: Global Recombinant Proteins Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 7: Global Recombinant Proteins Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 8: Asia-Pacific, Recombinant Proteins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 9: Asia-Pacific, Recombinant Proteins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 10: Asia-Pacific, Recombinant Proteins Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 11: China, Recombinant Proteins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 12: China, Recombinant Proteins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 13: China, Recombinant Proteins Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 14: India, Recombinant Proteins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 15: India, Recombinant Proteins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 16: India, Recombinant Proteins Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 17: Japan, Recombinant Proteins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 18: Japan, Recombinant Proteins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 19: Japan, Recombinant Proteins Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 20: Australia, Recombinant Proteins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 21: Australia, Recombinant Proteins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 22: Australia, Recombinant Proteins Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 23: Indonesia, Recombinant Proteins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 24: Indonesia, Recombinant Proteins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 25: Indonesia, Recombinant Proteins Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 26: South Korea, Recombinant Proteins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 27: South Korea, Recombinant Proteins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 28: South Korea, Recombinant Proteins Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 29: Western Europe, Recombinant Proteins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 30: Western Europe, Recombinant Proteins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 31: Western Europe, Recombinant Proteins Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 32: UK, Recombinant Proteins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 33: UK, Recombinant Proteins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 34: UK, Recombinant Proteins Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 35: Germany, Recombinant Proteins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 36: Germany, Recombinant Proteins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 37: Germany, Recombinant Proteins Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 38: France, Recombinant Proteins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 39: France, Recombinant Proteins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 40: France, Recombinant Proteins Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 41: Italy, Recombinant Proteins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 42: Italy, Recombinant Proteins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 43: Italy, Recombinant Proteins Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 44: Spain, Recombinant Proteins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 45: Spain, Recombinant Proteins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 46: Spain, Recombinant Proteins Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 47: Eastern Europe, Recombinant Proteins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 48: Eastern Europe, Recombinant Proteins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 49: Eastern Europe, Recombinant Proteins Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 50: Russia, Recombinant Proteins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 51: Russia, Recombinant Proteins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 52: Russia, Recombinant Proteins Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 53: North America, Recombinant Proteins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 54: North America, Recombinant Proteins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 55: North America, Recombinant Proteins Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 56: USA, Recombinant Proteins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 57: USA, Recombinant Proteins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 58: USA, Recombinant Proteins Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 59: Canada, Recombinant Proteins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 60: Canada, Recombinant Proteins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 61: Canada, Recombinant Proteins Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 62: South America, Recombinant Proteins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 63: South America, Recombinant Proteins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 64: South America, Recombinant Proteins Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 65: Brazil, Recombinant Proteins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 66: Brazil, Recombinant Proteins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 67: Brazil, Recombinant Proteins Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 68: Middle East, Recombinant Proteins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 69: Middle East, Recombinant Proteins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 70: Middle East, Recombinant Proteins Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 71: Africa, Recombinant Proteins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 72: Africa, Recombinant Proteins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 73: Africa, Recombinant Proteins Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 74: Abcam plc Financial Performance
  • Figure 75: Abnova Corporation Financial Performance
  • Figure 76: Bio-Rad Laboratoroies Inc. Financial Performance
  • Figure 77: Merck Co. &  KGaA Financial Performance
  • Figure 78: R&D Systems Inc. Financial Performance
Global Anesthesia Machines Market 2022 – Market Opportunities And Strategies
Read More
Latest Benign Prostatic Hyperplasia BPH Treatment Devices And Equipment Market Growth Study 2022-2026 By The Business Research Company
Read More
What Is The Computed Tomography CT Scanners Devices And Equipment Market Overview In 2022?
Read More
How Will The Laryngoscope Market Grow In 2022?
Read More
The Business Research Company offers the neuroscience antibodies and assays market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the narcotics scanner market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the aircraft doors market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the aircraft landing gear market research report 2022 with industry size, share, segments and market growth
Read More
Hair Preparations Global Market Report 2024 – By Type (Hair Spray, Conditioner, Shampoo, Hair Oil, Hair Color, Other Types), By Gender (Male, Female, Unisex), By Based On Type (Organic, Chemical), By Distribution Channel (Hypermarkets/Supermarkets, Specialty Stores, Online Stores, Convenience Stores, Other Distribution Channels) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Natural Hair Care Products Global Market Report 2024 – By Product Type (Shampoos, Conditioners, Oils And Serum, Gel And Wax, Hair Color, Other Product Types), By Gender (Men, Women, Other Genders), By Price Category (High Or Premium, Medium, Low), By Distribution Channel (Offline, Online) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Luxury Hair Care Products Global Market Report 2024 – By Product Type (Shampoos, Conditioners, Hair Coloring Products, Hair Styling Products, Hair Oil, Other Product Types), By Distribution Channel (Supermarkets and Hypermarkets, Departmental Stores, Specialty Stores, E-commerce, Other Distribution Channels) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Hair Color Global Market Report 2024 – By Usage (Permanent Hair Color, Semi-Permanent Hair Color, Demi-Permanent Hair Color, Temporary Hair Color, Hair Highlights and Bleach), By Distribution Channel (Offline, Online), By Application (Total Gray Coverage, Touch-Up For Roots, Grays Highlighting), By End-User (Male, Female, Unisex) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Hair Accessories Global Market Report 2024 – By Product Type (Clips and Pins, Headbands, Wigs and Extensions, Elastics and Ties, Other Products), By Distribution (Hypermarkets and Supermarkets, General Stores, Online or E-Commerce), By Application (Personal Application, Commercial Application) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Hair Styling Tools Global Market Report 2024 – By Type (Manual, Electric), By Product Type (Hair Dryers, Hair Curlers And Rollers, Hair Straighteners, Hair Styling Brushes And Combs, Others (Hair Scalp Massager)), By Distribution Channel (Hypermarkets And Supermarkets, Specialty Stores, Online Channels, Other Distribution Channels (Salons, Departmental Stores)), By Application (Household, Commercial) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Personal Care Ingredients Global Market Report 2024 – By Ingredients (Emollients, Surfactants, Emulsifiers, Rheology Modifiers, Conditioning Polymers, Other Ingredients), By Source (Natural Ingredients, Synthetic Ingredients), By Application (Skin Care, Hair Care, Oral Care, Cosmetics, Other Applications) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Retail And Wholesale Global Market Report 2024 – By Type (Retail, Wholesale), By Ownership (Retail Chain/Wholesale Chain, Independent Retailer/Independent Wholesalers), By Price Range (Premium, Mid Range, Economy), By Distribution Channel (Supermarkets/Hypermarkets, Convenience Stores, Department Stores, Specialty Stores, Online, Other Distribution Channels) – Market Size, Trends, And Global Forecast 2024-2033
View Report

Frequently Asked Questions

What is the definition of the recombinant proteins market?

Recombinant proteins refer to modified or edited proteins encoded by recombinant DNA, made up of a plasmid in which the gene of an interest target protein is cloned downstream of a promoter region. They are used to make pharmaceuticals, protein-based polymers for drug delivery, antibodies and enzymes for disease treatment, protein scaffolds for tissue engineering, and a variety of other things. For further insights on the recombinant proteins market, request a sample here

How will the recombinant proteins market drivers and restraints affect the recombinant proteins market dynamics? What forces will shape the recombinant proteins industry going forward?

The recombinant proteins market major growth driver - rising regulatory approvals fuel the growth of recombinant protein market. For further insights on the recombinant proteins market, request a sample here

What is the forecast market size or the forecast market value of the recombinant proteins market ?

The recombinant proteins market size has grown rapidly in recent years. It will grow from $2.12 billion in 2023 to $2.37 billion in 2024 at a compound annual growth rate (CAGR) of 11.6%. The growth in the historic period can be attributed to increasing demand for biopharmaceuticals, rising prevalence of chronic diseases, growing aging population, government initiatives and funding, expanding applications in research and diagnostics.. The recombinant proteins market size is expected to see rapid growth in the next few years. It will grow to $3.79 billion in 2028 at a compound annual growth rate (CAGR) of 12.5%. The growth in the forecast period can be attributed to increased adoption of personalized medicine, rapid expansion of the biotechnology sector, global efforts to address rare diseases, advancements in protein engineering techniques, emerging markets and untapped opportunities.. Major trends in the forecast period include expansion of personalized medicine, rapid growth in the biotechnology sector, demand for therapeutic proteins, emergence of novel therapeutic targets, global focus on vaccine development.. For further insights on the recombinant proteins market, request a sample here

How is the recombinant proteins market segmented?

The recombinant proteins market is segmented
1) By Product: Antibodies, Cytokines, Immune Checkpoint Protein, Virus Antigens, Enzymes, Recombinant Regulatory Proteins, Hormones, Other Products
2) By Application: Drug And Discovery Development, Therapeutics, Research, Other Applications
3) By End User: Pharmaceutical And Biotechnology Companies, Academic And Research Institute, Diagnostic Laboratories, Other End UsersFor further insights on the recombinant proteins market, request a sample here

Which region has the largest share of the recombinant proteins market? What are the other regions covered in the report?

North America was the largest region in the recombinant protein market in 2023. The regions covered in the recombinant proteins market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa For further insights on the recombinant proteins market, request a sample here.

Who are the major players in the recombinant proteins market?

Major companies operating in the recombinant proteins market report are Abcam plc, Abnova Corporation, Bio-Rad Laboratoroies Inc., Merck Co. & KGaA, R&D Systems Inc., Proteintech Group Inc., RayBiotech Life Inc., GenScript Biotech Corporation, Elpiscience Biopharmaceuticals Co. Ltd., Elevian Inc., Gigagen Inc., Janssen- Cilag Pvt. Ltd., Sino Biological Inc., OriGene Technologies Inc., Feldan Therapeutics Inc., Randox Laboratories Ltd., Plant Biotechnology Inc., Infinite Enzymes Inc., Bio-Techne Corporation, Thermo Fisher Scientific Inc., PerkinElmer Inc., Crown Bioscience Inc., Airway Therapeutics Inc., Amgen Inc., Aviva Systems Biology Corp., Bracco Imaging S.p.A., Cardinal Health Inc., Eli Lilly and Company, Gamma Medica Inc., LambdaSpect Ltd. . For further insights on the recombinant proteins market, request a sample here.

What are the key trends in the recombinant proteins market?

Major trend in the recombinant proteins market - innovative product developments driving recombinant protein market growth. For further insights on the recombinant proteins market, request a sample here.

What are the major opportunities in the recombinant proteins market? What are the strategies for the recombinant proteins market?

For detailed insights on the major opportunities and strategies in the recombinant proteins market, request a sample here.

How does the recombinant proteins market relate to the overall economy and other similar markets?

For detailed insights on recombinant proteins market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the recombinant proteins industry?

For detailed insights on the mergers and acquisitions in the recombinant proteins industry, request a sample here.

What are the key dynamics influencing the recombinant proteins market growth? SWOT analysis of the recombinant proteins market.

For detailed insights on the key dynamics influencing the recombinant proteins market growth and SWOT analysis of the recombinant proteins industry, request a sample here.